Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

Several dozen people gathered at Clovis Community Medical Center to celebrate patients living with a Left Ventricular Assist ...

The target patients for this therapy fell into three possible intentions of treatment or indications of VAD placement: BTT, for patients who are transplant candidates but who will not survive ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval ...

Implantation of the Ventura interatrial shunt, while safe, does not improve clinical outcomes or prognosis in patients with HF and preserved LVEF.

The authors reviewed insertion sites and techniques to ensure catheters reach ... Increased mean RA pressure in pulmonary ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

Can Heart Medicine Lead to Depression?All patients who have had a heart attack are typically treated using beta blockers.

Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...

Area Lions Clubs are hosting a benefit dinner to support Steve Smith, a resident who is in need of a heart transplant.

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.